Replies to post #1011 on TG Therapeutics Inc (TGTX)

[Selett]

You are 100% correct and your question is the right one.

The answer is yes and that's their potential $2-$5B annual market opportunity. That's why this will keep running (assuming good data).

The recent stuff is nice and I'll take it...but tackling B cells with minimal AE's is the big one.